-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
BridgeBio Pharma, Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2022 to Q3 2024.
- BridgeBio Pharma, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $598K, unchanged year-over-year.
- BridgeBio Pharma, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $2.39M.
- BridgeBio Pharma, Inc. annual Cost of Revenue for 2023 was $2.45M, a 28.8% decline from 2022.
- BridgeBio Pharma, Inc. annual Cost of Revenue for 2022 was $3.43M, a 10.3% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)